{
    "2021-08-24": [
        [
            {
                "time": "2021-08-24",
                "original_text": "智通港股早知道 | (8月24日)原油强势反弹结束七连跌，海运运价回升至一年最高点",
                "features": {
                    "keywords": [
                        "复星医药",
                        "新冠疫苗",
                        "mRNA技术",
                        "营收增长",
                        "创新药物"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-24",
                "original_text": "复星医药吴以芳：向创新药物迈进 不断提高创新品种收入比重",
                "features": {
                    "keywords": [
                        "创新药物",
                        "收入比重",
                        "战略目标"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-24",
                "original_text": "复星国际：上半年净利润逾40亿元，快乐板块业务仍然亏损",
                "features": {
                    "keywords": [
                        "净利润",
                        "亏损",
                        "快乐板块"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "多元化业务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-24",
                "original_text": "中银证券维持复星医药增持评级：新品种进入收获期，金融资产价值提升",
                "features": {
                    "keywords": [
                        "新品种",
                        "收获期",
                        "金融资产",
                        "价值提升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-24",
                "original_text": "复星医药实现营业收入169.52亿元，同比增长20.85%",
                "features": {
                    "keywords": [
                        "营业收入",
                        "同比增长",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-24",
                "original_text": "全球首款mRNA新冠疫苗获批！将实现国内本地化生产",
                "features": {
                    "keywords": [
                        "mRNA疫苗",
                        "FDA批准",
                        "本地化生产"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-24",
                "original_text": "复星医药出售公司资产，多家药企开启“瘦身模式”",
                "features": {
                    "keywords": [
                        "资产出售",
                        "瘦身模式",
                        "战略调整"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-24",
                "original_text": "复星医药半年净利润25亿同比增45%，核心创新药单品收入增2倍",
                "features": {
                    "keywords": [
                        "净利润",
                        "同比增长",
                        "创新药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}